Breakthrough Therapy (BT) Designation Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)
According to 99Strategy, the Global Breakthrough Therapy (BT) Designation Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Breakthrough Therapy (BT) Designation market, the market size and growth, as well as the major market participants.
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
- Asia Pacific
- North America
- Europe
- South America
- Middle East & Africa
- Roche
- Abbvie
- Novartis International AG
- Janssen
- BMS
- Eli Lilly
- Gilead
- Sanofi
- Regeneron
- Acadia
- Boehringer Ingelheim
- Amgen
- AstraZeneca
- GlaxoSmithKline
- Vertex
- Alexion
- Merck
- Jazz Pharmaceuticals
- Exelixis
- Eisai
- Takeda
- Pfizer
- Oncology
- Infectious Diseases
- Rare Diseases
- Autoimmune Diseases
- Pulmonary Diseases
- Neurological Disorders
- Others
- Hospital
- Clinic
- Research Institute
- Laboratories
- Overview of the Breakthrough Therapy (BT) Designation market including production, consumption, status & forecast and market growth
- 2015-2018 historical data and 2019-2025 market forecast
- Geographical analysis including major countries
- Overview the product type market including development
- Overview the end-user market including development
1 INDUSTRIAL CHAIN OVERVIEW
1.1 Breakthrough Therapy (BT) Designation Industry
1.1.1 Overview
1.1.2 Characteristics of Breakthrough Therapy (BT) Designation
1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview
1.3 Product List By Type
1.3.1 Oncology
1.3.2 Infectious Diseases
1.3.3 Rare Diseases
1.3.4 Autoimmune Diseases
1.3.5 Pulmonary Diseases
1.3.6 Neurological Disorders
1.3.7 Others
1.4 End-Use List
1.4.1 Demand in Hospital
1.4.2 Demand in Clinic
1.4.3 Demand in Research Institute
1.4.4 Demand in Laboratories
1.5 Global Market Overview
1.5.1 Global Market Size and Forecast, 2015-2025
1.5.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025
1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025
1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025
2 GLOBAL PRODUCTION & CONSUMPTION BY GEOGRAPHY
2.1 Global Production & Consumption
2.1.1 Global Production
2.1.2 Global Consumption
2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
2.2.1.2 North America
2.2.1.3 South America
2.2.1.4 Europe
2.2.1.5 Middle East & Africa
2.2.2 Consumption
2.2.2.1 Asia-Pacific
2.2.2.2 North America
2.2.2.3 South America
2.2.2.4 Europe
2.2.2.5 Middle East & Africa
3 MAJOR MANUFACTURERS INTRODUCTION
3.1 Manufacturers Overview
3.2 Manufacturers List
3.2.1 Roche Overview
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 Abbvie Overview
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 Novartis International AG Overview
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 Janssen Overview
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 BMS Overview
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 Eli Lilly Overview
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 Gilead Overview
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
3.2.8 Sanofi Overview
3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning
3.2.9 Regeneron Overview
3.2.9.1 Product Specifications
3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.9.3 Recent Developments
3.2.9.4 Future Strategic Planning
3.2.10 Acadia Overview
3.2.10.1 Product Specifications
3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.10.3 Recent Developments
3.2.10.4 Future Strategic Planning
3.2.11 Boehringer Ingelheim Overview
3.2.11.1 Product Specifications
3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.11.3 Recent Developments
3.2.11.4 Future Strategic Planning
3.2.12 Amgen Overview
3.2.12.1 Product Specifications
3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.12.3 Recent Developments
3.2.12.4 Future Strategic Planning
3.2.13 AstraZeneca Overview
3.2.13.1 Product Specifications
3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.13.3 Recent Developments
3.2.13.4 Future Strategic Planning
3.2.14 GlaxoSmithKline Overview
3.2.14.1 Product Specifications
3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.14.3 Recent Developments
3.2.14.4 Future Strategic Planning
3.2.15 Vertex Overview
3.2.15.1 Product Specifications
3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.15.3 Recent Developments
3.2.15.4 Future Strategic Planning
3.2.16 Alexion Overview
3.2.16.1 Product Specifications
3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.16.3 Recent Developments
3.2.16.4 Future Strategic Planning
3.2.17 Merck Overview
3.2.17.1 Product Specifications
3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.17.3 Recent Developments
3.2.17.4 Future Strategic Planning
3.2.18 Jazz Pharmaceuticals Overview
3.2.18.1 Product Specifications
3.2.18.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.18.3 Recent Developments
3.2.18.4 Future Strategic Planning
3.2.19 Exelixis Overview
3.2.19.1 Product Specifications
3.2.19.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.19.3 Recent Developments
3.2.19.4 Future Strategic Planning
3.2.20 Eisai Overview
3.2.20.1 Product Specifications
3.2.20.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.20.3 Recent Developments
3.2.20.4 Future Strategic Planning
3.2.21 Takeda Overview
3.2.21.1 Product Specifications
3.2.21.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.21.3 Recent Developments
3.2.21.4 Future Strategic Planning
3.2.22 Pfizer Overview
3.2.22.1 Product Specifications
3.2.22.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.22.3 Recent Developments
3.2.22.4 Future Strategic Planning
4 MARKET COMPETITION PATTERN
4.1 Market Size and Sketch
4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
4.2.2 Market Concentration Analysis
4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 PRODUCT TYPE SEGMENT
5.1 Global Overview by Product Type Segment
5.2 Segment Subdivision by Product Type
5.2.1 Market in Oncology
5.2.1.1 Market Size
5.2.1.2 Situation & Development
5.2.2 Market in Infectious Diseases
5.2.2.1 Market Size
5.2.2.2 Situation & Development
5.2.3 Market in Rare Diseases
5.2.3.1 Market Size
5.2.3.2 Situation & Development
5.2.4 Market in Autoimmune Diseases
5.2.4.1 Market Size
5.2.4.2 Situation & Development
5.2.5 Market in Pulmonary Diseases
5.2.5.1 Market Size
5.2.5.2 Situation & Development
5.2.6 Market in Neurological Disorders
5.2.6.1 Market Size
5.2.6.2 Situation & Development
5.2.7 Market in Others
5.2.7.1 Market Size
5.2.7.2 Situation & Development
6 END-USE SEGMENT
6.1 Global Overview by End-Use Segment
6.2 Segment Subdivision
6.2.1 Market in Hospital
6.2.1.1 Market Size
6.2.1.2 Situation & Development
6.2.2 Market in Clinic
6.2.2.1 Market Size
6.2.2.2 Situation & Development
6.2.3 Market in Research Institute
6.2.3.1 Market Size
6.2.3.2 Situation & Development
6.2.4 Market in Laboratories
6.2.4.1 Market Size
6.2.4.2 Situation & Development
7 MARKET FORECAST & TREND
7.1 Regional Forecast
7.2 Consumption Forecast
7.2.1 Product Type Forecast
7.2.2 End-Use Forecast
7.3 Investment Trend
7.4 Consumption Trend
8 PRICE & CHANNEL
8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
8.2 Channel Segment
9 MARKET DRIVERS & INVESTMENT ENVIRONMENT
9.1 Market Drivers
9.2 Investment Environment
10 RESEARCH CONCLUSION
1.1 Breakthrough Therapy (BT) Designation Industry
1.1.1 Overview
1.1.2 Characteristics of Breakthrough Therapy (BT) Designation
1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview
1.3 Product List By Type
1.3.1 Oncology
1.3.2 Infectious Diseases
1.3.3 Rare Diseases
1.3.4 Autoimmune Diseases
1.3.5 Pulmonary Diseases
1.3.6 Neurological Disorders
1.3.7 Others
1.4 End-Use List
1.4.1 Demand in Hospital
1.4.2 Demand in Clinic
1.4.3 Demand in Research Institute
1.4.4 Demand in Laboratories
1.5 Global Market Overview
1.5.1 Global Market Size and Forecast, 2015-2025
1.5.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025
1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025
1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025
2 GLOBAL PRODUCTION & CONSUMPTION BY GEOGRAPHY
2.1 Global Production & Consumption
2.1.1 Global Production
2.1.2 Global Consumption
2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
2.2.1.2 North America
2.2.1.3 South America
2.2.1.4 Europe
2.2.1.5 Middle East & Africa
2.2.2 Consumption
2.2.2.1 Asia-Pacific
2.2.2.2 North America
2.2.2.3 South America
2.2.2.4 Europe
2.2.2.5 Middle East & Africa
3 MAJOR MANUFACTURERS INTRODUCTION
3.1 Manufacturers Overview
3.2 Manufacturers List
3.2.1 Roche Overview
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 Abbvie Overview
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 Novartis International AG Overview
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 Janssen Overview
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 BMS Overview
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 Eli Lilly Overview
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 Gilead Overview
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
3.2.8 Sanofi Overview
3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning
3.2.9 Regeneron Overview
3.2.9.1 Product Specifications
3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.9.3 Recent Developments
3.2.9.4 Future Strategic Planning
3.2.10 Acadia Overview
3.2.10.1 Product Specifications
3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.10.3 Recent Developments
3.2.10.4 Future Strategic Planning
3.2.11 Boehringer Ingelheim Overview
3.2.11.1 Product Specifications
3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.11.3 Recent Developments
3.2.11.4 Future Strategic Planning
3.2.12 Amgen Overview
3.2.12.1 Product Specifications
3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.12.3 Recent Developments
3.2.12.4 Future Strategic Planning
3.2.13 AstraZeneca Overview
3.2.13.1 Product Specifications
3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.13.3 Recent Developments
3.2.13.4 Future Strategic Planning
3.2.14 GlaxoSmithKline Overview
3.2.14.1 Product Specifications
3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.14.3 Recent Developments
3.2.14.4 Future Strategic Planning
3.2.15 Vertex Overview
3.2.15.1 Product Specifications
3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.15.3 Recent Developments
3.2.15.4 Future Strategic Planning
3.2.16 Alexion Overview
3.2.16.1 Product Specifications
3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.16.3 Recent Developments
3.2.16.4 Future Strategic Planning
3.2.17 Merck Overview
3.2.17.1 Product Specifications
3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.17.3 Recent Developments
3.2.17.4 Future Strategic Planning
3.2.18 Jazz Pharmaceuticals Overview
3.2.18.1 Product Specifications
3.2.18.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.18.3 Recent Developments
3.2.18.4 Future Strategic Planning
3.2.19 Exelixis Overview
3.2.19.1 Product Specifications
3.2.19.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.19.3 Recent Developments
3.2.19.4 Future Strategic Planning
3.2.20 Eisai Overview
3.2.20.1 Product Specifications
3.2.20.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.20.3 Recent Developments
3.2.20.4 Future Strategic Planning
3.2.21 Takeda Overview
3.2.21.1 Product Specifications
3.2.21.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.21.3 Recent Developments
3.2.21.4 Future Strategic Planning
3.2.22 Pfizer Overview
3.2.22.1 Product Specifications
3.2.22.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.22.3 Recent Developments
3.2.22.4 Future Strategic Planning
4 MARKET COMPETITION PATTERN
4.1 Market Size and Sketch
4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
4.2.2 Market Concentration Analysis
4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 PRODUCT TYPE SEGMENT
5.1 Global Overview by Product Type Segment
5.2 Segment Subdivision by Product Type
5.2.1 Market in Oncology
5.2.1.1 Market Size
5.2.1.2 Situation & Development
5.2.2 Market in Infectious Diseases
5.2.2.1 Market Size
5.2.2.2 Situation & Development
5.2.3 Market in Rare Diseases
5.2.3.1 Market Size
5.2.3.2 Situation & Development
5.2.4 Market in Autoimmune Diseases
5.2.4.1 Market Size
5.2.4.2 Situation & Development
5.2.5 Market in Pulmonary Diseases
5.2.5.1 Market Size
5.2.5.2 Situation & Development
5.2.6 Market in Neurological Disorders
5.2.6.1 Market Size
5.2.6.2 Situation & Development
5.2.7 Market in Others
5.2.7.1 Market Size
5.2.7.2 Situation & Development
6 END-USE SEGMENT
6.1 Global Overview by End-Use Segment
6.2 Segment Subdivision
6.2.1 Market in Hospital
6.2.1.1 Market Size
6.2.1.2 Situation & Development
6.2.2 Market in Clinic
6.2.2.1 Market Size
6.2.2.2 Situation & Development
6.2.3 Market in Research Institute
6.2.3.1 Market Size
6.2.3.2 Situation & Development
6.2.4 Market in Laboratories
6.2.4.1 Market Size
6.2.4.2 Situation & Development
7 MARKET FORECAST & TREND
7.1 Regional Forecast
7.2 Consumption Forecast
7.2.1 Product Type Forecast
7.2.2 End-Use Forecast
7.3 Investment Trend
7.4 Consumption Trend
8 PRICE & CHANNEL
8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
8.2 Channel Segment
9 MARKET DRIVERS & INVESTMENT ENVIRONMENT
9.1 Market Drivers
9.2 Investment Environment
10 RESEARCH CONCLUSION
LIST OF TABLES
Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025
Table Global Market Size and Forecast by Type with Growth Rate, 2015-2025
Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025
Table Global Production Volume Status and Growth Rate by Geography, 2015-2018, in Volume
Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD
Table Global Market Volume and Growth Rate by Geography, 2015-2018, in Volume
Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table North America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table South America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Asia-Pacific Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table North America Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Middle East & Africa Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2018
Table Roche Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Roche (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Abbvie Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Abbvie (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Novartis International AG Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Novartis International AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Janssen Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Janssen (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table BMS Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of BMS (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Eli Lilly (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Gilead Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Gilead (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Sanofi (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Regeneron Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Regeneron (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Acadia Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Acadia (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Boehringer Ingelheim (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Amgen Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Amgen (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of AstraZeneca (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of GlaxoSmithKline (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Vertex Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Vertex (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Alexion Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Alexion (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Merck Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Merck (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Jazz Pharmaceuticals Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Jazz Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Exelixis Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Exelixis (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Eisai Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Eisai (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Takeda Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Takeda (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Pfizer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Global Production Volume List by Manufacturers, 2015-2018, in Volume
Table Global Production Volume Share List by Manufacturers, 2015-2018, in Volume
Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD
Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2015-2018, in Volume
Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2015-2018, in Volume
Table Global Market Forecast by Region Segment 2019-2025, in Million USD
Table Global Market Forecast by Region Segment 2019-2025, in Volume
Table Global Market Amount by Product Type Segment 2019-2025, in Million USD
Table Global Market Volume by Product Type Segment 2019-2025, in Volume
Table Global Market Amount by End-Use Segment 2019-2025, in Million USD
Table Global Market Volume by End-Use Segment 2019-2025, in Volume
Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025
Table Global Market Size and Forecast by Type with Growth Rate, 2015-2025
Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025
Table Global Production Volume Status and Growth Rate by Geography, 2015-2018, in Volume
Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD
Table Global Market Volume and Growth Rate by Geography, 2015-2018, in Volume
Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table North America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table South America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Asia-Pacific Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table North America Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Middle East & Africa Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2018
Table Roche Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Roche (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Abbvie Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Abbvie (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Novartis International AG Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Novartis International AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Janssen Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Janssen (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table BMS Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of BMS (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Eli Lilly (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Gilead Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Gilead (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Sanofi (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Regeneron Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Regeneron (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Acadia Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Acadia (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Boehringer Ingelheim (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Amgen Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Amgen (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of AstraZeneca (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of GlaxoSmithKline (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Vertex Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Vertex (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Alexion Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Alexion (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Merck Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Merck (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Jazz Pharmaceuticals Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Jazz Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Exelixis Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Exelixis (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Eisai Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Eisai (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Takeda Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Takeda (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Pfizer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Global Production Volume List by Manufacturers, 2015-2018, in Volume
Table Global Production Volume Share List by Manufacturers, 2015-2018, in Volume
Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD
Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2015-2018, in Volume
Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2015-2018, in Volume
Table Global Market Forecast by Region Segment 2019-2025, in Million USD
Table Global Market Forecast by Region Segment 2019-2025, in Volume
Table Global Market Amount by Product Type Segment 2019-2025, in Million USD
Table Global Market Volume by Product Type Segment 2019-2025, in Volume
Table Global Market Amount by End-Use Segment 2019-2025, in Million USD
Table Global Market Volume by End-Use Segment 2019-2025, in Volume
LIST OF FIGURES
Figure Breakthrough Therapy (BT) Designation Picture List
Figure Global Market Size and Forecast with Growth Rate, 2015-2025
Figure Global Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Global Market Volume and Growth Rate, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Asia-Pacific Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure North America Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure South America Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Europe Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Middle East & Africa Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Asia-Pacific Market Volume and Growth Rate, 2015-2018, in Volume
Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD
Figure North America Market Volume and Growth Rate, 2015-2018, in Volume
Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume
Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume
Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Middle East & Africa Market Volume and Growth Rate, 2015-2018, in Volume
Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Global Production Volume Share by Manufacturers in 2019, in Volume
Figure Global Production Amount Share by Manufacturers in 2019, in Million USD
Figure Global Market Amount and Growth Rate in Oncology , 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Oncology , 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Infectious Diseases , 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Infectious Diseases , 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Rare Diseases , 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Rare Diseases , 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Autoimmune Diseases , 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Autoimmune Diseases , 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Pulmonary Diseases , 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Pulmonary Diseases , 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Neurological Disorders , 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Neurological Disorders , 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Hospital , 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Hospital , 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Clinic , 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Clinic , 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Research Institute , 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Research Institute , 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Laboratories, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Laboratories, 2015-2018, in Volume
Figure Breakthrough Therapy (BT) Designation Picture List
Figure Global Market Size and Forecast with Growth Rate, 2015-2025
Figure Global Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Global Market Volume and Growth Rate, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Asia-Pacific Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure North America Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure South America Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Europe Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Middle East & Africa Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Asia-Pacific Market Volume and Growth Rate, 2015-2018, in Volume
Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD
Figure North America Market Volume and Growth Rate, 2015-2018, in Volume
Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume
Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume
Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Middle East & Africa Market Volume and Growth Rate, 2015-2018, in Volume
Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Global Production Volume Share by Manufacturers in 2019, in Volume
Figure Global Production Amount Share by Manufacturers in 2019, in Million USD
Figure Global Market Amount and Growth Rate in Oncology , 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Oncology , 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Infectious Diseases , 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Infectious Diseases , 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Rare Diseases , 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Rare Diseases , 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Autoimmune Diseases , 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Autoimmune Diseases , 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Pulmonary Diseases , 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Pulmonary Diseases , 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Neurological Disorders , 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Neurological Disorders , 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Hospital , 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Hospital , 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Clinic , 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Clinic , 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Research Institute , 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Research Institute , 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Laboratories, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Laboratories, 2015-2018, in Volume
